ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anemia Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-29N8511
Home | Market Reports | Health| Health Conditions
Global Anemia Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anemia Drugs Market Research Report 2025

Code: QYRE-Auto-29N8511
Report
August 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Global Blood Therapeutics (GBT)
Bluebird bio
GlycoMimetics
Mast Therapeutics
FibroGen Inc
Akebia Therapeutics
Bayer
Eli Lilly
Regen BioPharma
Acceleron Pharma
Celgene Corporation
Onconova Therapeutics
Pieris Pharmaceuticals

Anemia Drugs Market Size

The global market for Anemia Drugs was valued at US$ 13280 million in the year 2024 and is projected to reach a revised size of US$ 18000 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Anemia Drugs Market

Anemia Drugs Market

North American market for Anemia Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Anemia Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Anemia Drugs include GlaxoSmithKline, Global Blood Therapeutics (GBT), Bluebird Bio, GlycoMimetics, Mast Therapeutics, Fibrogen, Akebia Therapeutics, Bayer AG, Eli Lilly, Regen Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anemia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anemia Drugs.
The Anemia Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anemia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anemia Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anemia Drugs Market Report

Report Metric Details
Report Name Anemia Drugs Market
Accounted market size in year US$ 13280 million
Forecasted market size in 2031 US$ 18000 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Iron Deficiency Anemia
  • Chronic Kidney Disease related Anemia
  • Sickle Cell Anemia
  • Aplastic Anemia
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Global Blood Therapeutics (GBT), Bluebird Bio, GlycoMimetics, Mast Therapeutics, Fibrogen, Akebia Therapeutics, Bayer AG, Eli Lilly, Regen Biopharma, Acceleron Pharma, Celgene Corporation, Onconova Therapeutics, Pieris Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anemia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anemia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Anemia Drugs Market growing?

Ans: The Anemia Drugs Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Anemia Drugs Market size in 2031?

Ans: The Anemia Drugs Market size in 2031 will be US$ 18000 million.

Who are the main players in the Anemia Drugs Market report?

Ans: The main players in the Anemia Drugs Market are GlaxoSmithKline, Global Blood Therapeutics (GBT), Bluebird Bio, GlycoMimetics, Mast Therapeutics, Fibrogen, Akebia Therapeutics, Bayer AG, Eli Lilly, Regen Biopharma, Acceleron Pharma, Celgene Corporation, Onconova Therapeutics, Pieris Pharmaceuticals

What are the Application segmentation covered in the Anemia Drugs Market report?

Ans: The Applications covered in the Anemia Drugs Market report are Iron Deficiency Anemia, Chronic Kidney Disease related Anemia, Sickle Cell Anemia, Aplastic Anemia

What are the Type segmentation covered in the Anemia Drugs Market report?

Ans: The Types covered in the Anemia Drugs Market report are Oral, Injection

1 Anemia Drugs Market Overview
1.1 Product Definition
1.2 Anemia Drugs by Type
1.2.1 Global Anemia Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.3 Anemia Drugs by Application
1.3.1 Global Anemia Drugs Market Value by Application (2024 VS 2031)
1.3.2 Iron Deficiency Anemia
1.3.3 Chronic Kidney Disease related Anemia
1.3.4 Sickle Cell Anemia
1.3.5 Aplastic Anemia
1.4 Global Anemia Drugs Market Size Estimates and Forecasts
1.4.1 Global Anemia Drugs Revenue 2020-2031
1.4.2 Global Anemia Drugs Sales 2020-2031
1.4.3 Global Anemia Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anemia Drugs Market Competition by Manufacturers
2.1 Global Anemia Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anemia Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anemia Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anemia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anemia Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anemia Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anemia Drugs, Date of Enter into This Industry
2.8 Global Anemia Drugs Market Competitive Situation and Trends
2.8.1 Global Anemia Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anemia Drugs Players Market Share by Revenue
2.8.3 Global Anemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anemia Drugs Market Scenario by Region
3.1 Global Anemia Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anemia Drugs Sales by Region: 2020-2031
3.2.1 Global Anemia Drugs Sales by Region: 2020-2025
3.2.2 Global Anemia Drugs Sales by Region: 2026-2031
3.3 Global Anemia Drugs Revenue by Region: 2020-2031
3.3.1 Global Anemia Drugs Revenue by Region: 2020-2025
3.3.2 Global Anemia Drugs Revenue by Region: 2026-2031
3.4 North America Anemia Drugs Market Facts & Figures by Country
3.4.1 North America Anemia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anemia Drugs Sales by Country (2020-2031)
3.4.3 North America Anemia Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anemia Drugs Market Facts & Figures by Country
3.5.1 Europe Anemia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anemia Drugs Sales by Country (2020-2031)
3.5.3 Europe Anemia Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anemia Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anemia Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anemia Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anemia Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anemia Drugs Market Facts & Figures by Country
3.7.1 Latin America Anemia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anemia Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anemia Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anemia Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anemia Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anemia Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anemia Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anemia Drugs Sales by Type (2020-2031)
4.1.1 Global Anemia Drugs Sales by Type (2020-2025)
4.1.2 Global Anemia Drugs Sales by Type (2026-2031)
4.1.3 Global Anemia Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anemia Drugs Revenue by Type (2020-2031)
4.2.1 Global Anemia Drugs Revenue by Type (2020-2025)
4.2.2 Global Anemia Drugs Revenue by Type (2026-2031)
4.2.3 Global Anemia Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anemia Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anemia Drugs Sales by Application (2020-2031)
5.1.1 Global Anemia Drugs Sales by Application (2020-2025)
5.1.2 Global Anemia Drugs Sales by Application (2026-2031)
5.1.3 Global Anemia Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anemia Drugs Revenue by Application (2020-2031)
5.2.1 Global Anemia Drugs Revenue by Application (2020-2025)
5.2.2 Global Anemia Drugs Revenue by Application (2026-2031)
5.2.3 Global Anemia Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anemia Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Anemia Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Global Blood Therapeutics (GBT)
6.2.1 Global Blood Therapeutics (GBT) Company Information
6.2.2 Global Blood Therapeutics (GBT) Description and Business Overview
6.2.3 Global Blood Therapeutics (GBT) Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Global Blood Therapeutics (GBT) Anemia Drugs Product Portfolio
6.2.5 Global Blood Therapeutics (GBT) Recent Developments/Updates
6.3 Bluebird Bio
6.3.1 Bluebird Bio Company Information
6.3.2 Bluebird Bio Description and Business Overview
6.3.3 Bluebird Bio Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bluebird Bio Anemia Drugs Product Portfolio
6.3.5 Bluebird Bio Recent Developments/Updates
6.4 GlycoMimetics
6.4.1 GlycoMimetics Company Information
6.4.2 GlycoMimetics Description and Business Overview
6.4.3 GlycoMimetics Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GlycoMimetics Anemia Drugs Product Portfolio
6.4.5 GlycoMimetics Recent Developments/Updates
6.5 Mast Therapeutics
6.5.1 Mast Therapeutics Company Information
6.5.2 Mast Therapeutics Description and Business Overview
6.5.3 Mast Therapeutics Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mast Therapeutics Anemia Drugs Product Portfolio
6.5.5 Mast Therapeutics Recent Developments/Updates
6.6 Fibrogen
6.6.1 Fibrogen Company Information
6.6.2 Fibrogen Description and Business Overview
6.6.3 Fibrogen Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fibrogen Anemia Drugs Product Portfolio
6.6.5 Fibrogen Recent Developments/Updates
6.7 Akebia Therapeutics
6.7.1 Akebia Therapeutics Company Information
6.7.2 Akebia Therapeutics Description and Business Overview
6.7.3 Akebia Therapeutics Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Akebia Therapeutics Anemia Drugs Product Portfolio
6.7.5 Akebia Therapeutics Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Company Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer AG Anemia Drugs Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Company Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Eli Lilly Anemia Drugs Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Regen Biopharma
6.10.1 Regen Biopharma Company Information
6.10.2 Regen Biopharma Description and Business Overview
6.10.3 Regen Biopharma Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Regen Biopharma Anemia Drugs Product Portfolio
6.10.5 Regen Biopharma Recent Developments/Updates
6.11 Acceleron Pharma
6.11.1 Acceleron Pharma Company Information
6.11.2 Acceleron Pharma Description and Business Overview
6.11.3 Acceleron Pharma Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Acceleron Pharma Anemia Drugs Product Portfolio
6.11.5 Acceleron Pharma Recent Developments/Updates
6.12 Celgene Corporation
6.12.1 Celgene Corporation Company Information
6.12.2 Celgene Corporation Description and Business Overview
6.12.3 Celgene Corporation Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Celgene Corporation Anemia Drugs Product Portfolio
6.12.5 Celgene Corporation Recent Developments/Updates
6.13 Onconova Therapeutics
6.13.1 Onconova Therapeutics Company Information
6.13.2 Onconova Therapeutics Description and Business Overview
6.13.3 Onconova Therapeutics Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Onconova Therapeutics Anemia Drugs Product Portfolio
6.13.5 Onconova Therapeutics Recent Developments/Updates
6.14 Pieris Pharmaceuticals
6.14.1 Pieris Pharmaceuticals Company Information
6.14.2 Pieris Pharmaceuticals Description and Business Overview
6.14.3 Pieris Pharmaceuticals Anemia Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Pieris Pharmaceuticals Anemia Drugs Product Portfolio
6.14.5 Pieris Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anemia Drugs Industry Chain Analysis
7.2 Anemia Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anemia Drugs Production Mode & Process Analysis
7.4 Anemia Drugs Sales and Marketing
7.4.1 Anemia Drugs Sales Channels
7.4.2 Anemia Drugs Distributors
7.5 Anemia Drugs Customer Analysis
8 Anemia Drugs Market Dynamics
8.1 Anemia Drugs Industry Trends
8.2 Anemia Drugs Market Drivers
8.3 Anemia Drugs Market Challenges
8.4 Anemia Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Global Blood Therapeutics (GBT)
Bluebird bio
GlycoMimetics
Mast Therapeutics
FibroGen Inc
Akebia Therapeutics
Bayer
Eli Lilly
Regen BioPharma
Acceleron Pharma
Celgene Corporation
Onconova Therapeutics
Pieris Pharmaceuticals
List of Tables
 Table 1. Global Anemia Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anemia Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anemia Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anemia Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Anemia Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anemia Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anemia Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anemia Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anemia Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anemia Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anemia Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Anemia Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anemia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anemia Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anemia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anemia Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Anemia Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Anemia Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Anemia Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Anemia Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anemia Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Anemia Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anemia Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Anemia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anemia Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Anemia Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Anemia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anemia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anemia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anemia Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Anemia Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Anemia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anemia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anemia Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anemia Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Anemia Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Anemia Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anemia Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anemia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anemia Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Anemia Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Anemia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anemia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anemia Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anemia Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Anemia Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Anemia Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anemia Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anemia Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Anemia Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Anemia Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Anemia Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Anemia Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anemia Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anemia Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Anemia Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Anemia Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Anemia Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Anemia Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Anemia Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Anemia Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Anemia Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Anemia Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anemia Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anemia Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Anemia Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Anemia Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Anemia Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Anemia Drugs Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Global Blood Therapeutics (GBT) Company Information
 Table 76. Global Blood Therapeutics (GBT) Description and Business Overview
 Table 77. Global Blood Therapeutics (GBT) Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Global Blood Therapeutics (GBT) Anemia Drugs Product
 Table 79. Global Blood Therapeutics (GBT) Recent Developments/Updates
 Table 80. Bluebird Bio Company Information
 Table 81. Bluebird Bio Description and Business Overview
 Table 82. Bluebird Bio Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Bluebird Bio Anemia Drugs Product
 Table 84. Bluebird Bio Recent Developments/Updates
 Table 85. GlycoMimetics Company Information
 Table 86. GlycoMimetics Description and Business Overview
 Table 87. GlycoMimetics Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. GlycoMimetics Anemia Drugs Product
 Table 89. GlycoMimetics Recent Developments/Updates
 Table 90. Mast Therapeutics Company Information
 Table 91. Mast Therapeutics Description and Business Overview
 Table 92. Mast Therapeutics Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Mast Therapeutics Anemia Drugs Product
 Table 94. Mast Therapeutics Recent Developments/Updates
 Table 95. Fibrogen Company Information
 Table 96. Fibrogen Description and Business Overview
 Table 97. Fibrogen Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Fibrogen Anemia Drugs Product
 Table 99. Fibrogen Recent Developments/Updates
 Table 100. Akebia Therapeutics Company Information
 Table 101. Akebia Therapeutics Description and Business Overview
 Table 102. Akebia Therapeutics Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Akebia Therapeutics Anemia Drugs Product
 Table 104. Akebia Therapeutics Recent Developments/Updates
 Table 105. Bayer AG Company Information
 Table 106. Bayer AG Description and Business Overview
 Table 107. Bayer AG Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Bayer AG Anemia Drugs Product
 Table 109. Bayer AG Recent Developments/Updates
 Table 110. Eli Lilly Company Information
 Table 111. Eli Lilly Description and Business Overview
 Table 112. Eli Lilly Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Eli Lilly Anemia Drugs Product
 Table 114. Eli Lilly Recent Developments/Updates
 Table 115. Regen Biopharma Company Information
 Table 116. Regen Biopharma Description and Business Overview
 Table 117. Regen Biopharma Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Regen Biopharma Anemia Drugs Product
 Table 119. Regen Biopharma Recent Developments/Updates
 Table 120. Acceleron Pharma Company Information
 Table 121. Acceleron Pharma Description and Business Overview
 Table 122. Acceleron Pharma Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Acceleron Pharma Anemia Drugs Product
 Table 124. Acceleron Pharma Recent Developments/Updates
 Table 125. Celgene Corporation Company Information
 Table 126. Celgene Corporation Description and Business Overview
 Table 127. Celgene Corporation Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 128. Celgene Corporation Anemia Drugs Product
 Table 129. Celgene Corporation Recent Developments/Updates
 Table 130. Onconova Therapeutics Company Information
 Table 131. Onconova Therapeutics Description and Business Overview
 Table 132. Onconova Therapeutics Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 133. Onconova Therapeutics Anemia Drugs Product
 Table 134. Onconova Therapeutics Recent Developments/Updates
 Table 135. Pieris Pharmaceuticals Company Information
 Table 136. Pieris Pharmaceuticals Description and Business Overview
 Table 137. Pieris Pharmaceuticals Anemia Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 138. Pieris Pharmaceuticals Anemia Drugs Product
 Table 139. Pieris Pharmaceuticals Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Anemia Drugs Distributors List
 Table 143. Anemia Drugs Customers List
 Table 144. Anemia Drugs Market Trends
 Table 145. Anemia Drugs Market Drivers
 Table 146. Anemia Drugs Market Challenges
 Table 147. Anemia Drugs Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anemia Drugs
 Figure 2. Global Anemia Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anemia Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Anemia Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anemia Drugs Market Share by Application: 2024 & 2031
 Figure 8. Iron Deficiency Anemia
 Figure 9. Chronic Kidney Disease related Anemia
 Figure 10. Sickle Cell Anemia
 Figure 11. Aplastic Anemia
 Figure 12. Global Anemia Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Anemia Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Anemia Drugs Sales (2020-2031) & (K Pcs)
 Figure 15. Global Anemia Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 16. Anemia Drugs Report Years Considered
 Figure 17. Anemia Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Anemia Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Anemia Drugs Players: Market Share by Revenue in Anemia Drugs in 2024
 Figure 20. Anemia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Anemia Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Anemia Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Anemia Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Anemia Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Anemia Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Anemia Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Anemia Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Anemia Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Anemia Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Anemia Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Anemia Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Anemia Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Anemia Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Anemia Drugs by Type (2020-2031)
 Figure 57. Global Anemia Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Anemia Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Anemia Drugs by Application (2020-2031)
 Figure 60. Global Anemia Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 61. Anemia Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Anti anemia Drugs Market Research Report 2024
Global Anemia Therapeutic Drugs Market Research Report 2024
Global Anemia Treatment Market Research Report 2024
Global Anemia Treatment Drugs Market Insights Forecast to 2030
Global Chemotherapy Induced Anemia Drug Market Research Report 2024
Anemia in Pregnancy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Anemia Therapeutics Market Research Report 2025
Global Anemia Screening Test Market Research Report 2025
Epoetin alfa Erythropoietin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IV and Oral Iron Drugs Market Insights Forecast to 2030
Global Women s Health Products Market Research Report 2024
Anemia Gene Detection Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Epoetin beta Erythropoietin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neutropenia Drugs Market Research Report 2025
Global Poloxamine Market Research Report 2025
Global Anemia Supplement Market Research Report 2024
Global Albumin Human Market Research Report 2024
Global Hair Color Products Market Research Report 2024
Global Pyrimethamine Market Research Report 2025
Global Pernicious Anemia Diagnosis and Treatment Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions